Effectiveness of adjuvant chemotherapy for resected NSCLC

被引：4
|
作者：
Stuschke, Martin [1 ]
Poettgen, Christoph [1 ]
机构：
[1] Univ Duisburg Essen, Dept Radiotherapy, D-45122 Essen, Germany
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2010年 / 7卷 / 11期
关键词：
CELL LUNG-CANCER; RADIOTHERAPY; GUIDELINE; THERAPY; SOCIETY; TRIAL; IIIA;
D O I：
10.1038/nrclinonc.2010.165
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two meta-analyses of the Non Small Cell Lung Cancer Meta-analyses Collaborative Group (NSCLC MACG) on the effects of adjuvant chemotherapy on early stage NSCLC after complete or curative resection have demonstrated that adjuvant cisplatin-based regimens are a valid and recommendable option following curative surgery. We discuss these results in the light of current interdisciplinary guidelines and existing meta-analyses of randomized clinical trials.
引用
收藏
页码：613 / 614
页数：2
相关论文
共 50 条
  • [1] Effectiveness of adjuvant chemotherapy for resected NSCLC
    Martin Stuschke
    Christoph Pöttgen
    [J]. Nature Reviews Clinical Oncology, 2010, 7 : 613 - 614
  • [2] ESTIMATING SURVIVAL AFTER ADJUVANT CHEMOTHERAPY FOR RESECTED NSCLC
    McCaughan, G.
    Blinman, P.
    Boyer, M.
    Stockler, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S31 - S31
  • [3] A single institution experience of adjuvant chemotherapy for resected NSCLC
    Taylor, P.
    Benrajab, A.
    Summers, Y.
    Bishop, P.
    Shah, R.
    Thatcher, N.
    [J]. LUNG CANCER, 2010, 67 : S8 - S8
  • [4] Use of adjuvant chemotherapy in resected early stage NSCLC in Grampian
    Brown, L.
    Kennedy, A.
    McLaughlin, L.
    Nicolson, M.
    [J]. LUNG CANCER, 2007, 57 : S5 - S6
  • [5] ADJUVANT CHEMOTHERAPY IN RESECTED NSCLC: TREATMENT FACTORS THAT IMPACT SURVIVAL OUTCOMES
    Ramsden, K.
    Laskin, J.
    Ho, C.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (04) : S31 - S32
  • [6] Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
    Bin Qiu
    Wei Guo
    Fan Zhang
    Fang Lv
    Ying Ji
    Yue Peng
    Xiaoxi Chen
    Hua Bao
    Yang Xu
    Yang Shao
    Fengwei Tan
    Qi Xue
    Shugeng Gao
    Jie He
    [J]. Nature Communications, 12
  • [7] Long-Term Results of Adjuvant Chemotherapy in Completely Resected NSCLC Patients
    Wurstbauer, Karl
    Sedlmayer, Felix
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 404 - 405
  • [8] Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
    Qiu, Bin
    Guo, Wei
    Zhang, Fan
    Lv, Fang
    Ji, Ying
    Peng, Yue
    Chen, Xiaoxi
    Bao, Hua
    Xu, Yang
    Shao, Yang
    Tan, Fengwei
    Xue, Qi
    Gao, Shugeng
    He, Jie
    [J]. NATURE COMMUNICATIONS, 2021, 12 (01)
  • [9] Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC
    Sorensen, Steffen Filskov
    Carus, Andreas
    Meldgaard, Peter
    [J]. LUNG CANCER, 2015, 88 (02) : 167 - 173
  • [10] Adjuvant targeted therapy for resected NSCLC: to be or not to be?
    Ye, Ting
    Chen, Haiquan
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3297 - S3299
12345